$SOPH News

SOPHiA GENETICS SA 2026 Q2 - Results - Earnings Call Presentation

HC Wainwright & Co. Maintains Buy on Sophia Genetics, Raises Price Target to $14

BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $9

SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call Transcript

SOPHiA GENETICS (NASDAQ:SOPH) Beats Q2 Revenue Estimates, Shares Rise Despite Wider Loss

Sophia Genetics Raises FY2026 Sales Guidance from $92.000M-$94.000M to $94.000M-$96.000M vs $93.403M Est

Sophia Genetics Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $23.310M Beat $21.729M Estimate

HC Wainwright & Co. Initiates Coverage On Sophia Genetics with Buy Rating, Announces Price Target of $12

SOPHiA Genetics: Strong Growth Meets A Critical Execution Phase

SOPHiA GENETICS Commences Ordinary Shares Offering; Terms Undisclosed

BTIG Reiterates Buy on Sophia Genetics, Maintains $8 Price Target

SOPHiA GENETICS Appoints President Ross Muken As CEO, Effective July 1, Succeeding Jurgi Camblong, Who Has Been Nominated As Board Chairman

SOPHiA GENETICS Inks MoU With Memorial Sloan Kettering Cancer Center To Form JV Between Two Institutions

SOPHiA GENETICS SA 2026 Q1 - Results - Earnings Call Presentation

BTIG Reiterates Buy on Sophia Genetics, Maintains $8 Price Target

SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary

SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript

SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript

BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8

SOPHiA GENETICS (NASDAQ:SOPH) Q1 Revenue Beats Estimates but Earnings Miss Sparks Pre-Market Decline